LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential
about
Maintaining Genome Stability in Defiance of Mitotic DNA DamageThe broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillancePP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells.Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options.Enhancing Therapeutic Efficacy of Cisplatin by Blocking DNA Damage Repair.LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation.Identifying and analyzing different cancer subtypes using RNA-seq data of blood platelets.Digoxin enhances radiation response in radioresistant A549 cells by reducing protein phosphatase 2A.PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer.Therapeutic Targeting of PP2A.Evidence that PP2A activity is dispensable for spindle assembly checkpoint-dependent control of Cdk1.Transient PP2A inhibition alleviates normal tissue stem cell susceptibility to cell death during radiotherapy.The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications.The impact of phosphatases on proliferative and survival signaling in cancer.Pharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade.An Ultra-High-Throughput Screen for Catalytic Inhibitors of Serine/Threonine Protein Phosphatases Types 1 and 5 (PP1C and PP5C)PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heartHigh-Throughput Screening of Identifies Compounds Which Target Both Life Cycle Stages and Which Are Effective Against Metronidazole Resistant Parasites
P2860
Q26738970-FA0566E1-1202-47AE-8529-B6CBCBCE8BBFQ26739246-542C5791-FF90-466D-9EE3-3F4C69FDB744Q37022200-DA0C3EC5-3ABF-4BE6-AB4C-6A18D8E05C16Q38904928-64BE704C-0B8C-4F3C-B471-EFBC75FEE868Q42108356-B93D7ED7-34EC-47B6-99A9-DE8788FFC991Q45074588-47A366CD-E0E1-4429-AA70-B744F58FB85AQ45943794-26262DDA-2D61-445E-92ED-D1B7C89D4817Q47146141-0BC56030-DFA2-4194-A95A-675D47A8699CQ47271622-815F65BB-6B29-4C47-AC4A-5EF7A1306D72Q47436859-309D09F2-6D1A-4F9E-9EB9-0751A3877927Q50332985-E4C44351-E8C0-43CD-8826-BCAD024E0CD2Q52715830-DE75C9F7-9411-42A8-A39C-ECA9CB4D5CB0Q52777531-711F5920-2BF6-430A-89F8-DA7B25B04912Q54112403-54962B51-B595-483B-A654-6EA3D11C02D5Q54967100-AAE34F1D-5709-4FD2-AA31-8EC74EA02E1BQ56788667-A75D24A0-CED3-4BAC-B3A8-D7A9C9E4E107Q57174535-7280FED9-CD8B-437F-8166-0C40EA8C85B6Q58769320-7B8F0C2E-A1B8-4418-98F8-7F6747C1DFC2
P2860
LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
LB100, a small molecule inhibi ...... nd radio-sensitizing potential
@ast
LB100, a small molecule inhibi ...... nd radio-sensitizing potential
@en
LB100, a small molecule inhibi ...... nd radio-sensitizing potential
@nl
type
label
LB100, a small molecule inhibi ...... nd radio-sensitizing potential
@ast
LB100, a small molecule inhibi ...... nd radio-sensitizing potential
@en
LB100, a small molecule inhibi ...... nd radio-sensitizing potential
@nl
prefLabel
LB100, a small molecule inhibi ...... nd radio-sensitizing potential
@ast
LB100, a small molecule inhibi ...... nd radio-sensitizing potential
@en
LB100, a small molecule inhibi ...... nd radio-sensitizing potential
@nl
P2093
P2860
P3181
P1476
LB100, a small molecule inhibi ...... nd radio-sensitizing potential
@en
P2093
Chao Zhang
Christopher S Hong
J Bradley Elder
Zhengping Zhuang
P2860
P304
P3181
P356
10.1080/15384047.2015.1040961
P407
P577
2015-04-21T00:00:00Z